Seach Medical Group
Company page · Medical cannabis

Seach Medical Group

TASE : SEMGISIN : IL0002490113Headquarters: Ramat GanIFRS accounts · in ₪M

Seach Medical Group Ltd manufactures and sells medicinal cannabis products worldwide. Based in Ramat Gan.

Price₪2.78+2.8% · session of 12/11/2026
Market cap₪92Mprice × number of shares
Next resultsno later than 30/11/2026Quarterly report
1-year price+2.9% over the period
Analysis in brief · H1 2026

Seach Medical Group: net income sharply up (+128.4%), sales down (−3.6%), operating income sharply up (+55.0%).

  • Net income sharply up

    Net income: ₪10M, vs. ₪4M a year earlier, i.e. +128.4%.

    H1 2026
  • Sales down

    Revenue: ₪75M, vs. ₪78M a year earlier, i.e. −3.6%.

    H1 2026
  • Operating income sharply up

    Operating income: ₪10M, vs. ₪6M a year earlier, i.e. +55.0%.

    H1 2026
  • Cash flow up

    Operating cash flow: ₪15M, vs. ₪15M a year earlier, i.e. +2.1%.

    H1 2026
Built automatically from the published figures.
Valuation

What the market pays, vs. the sector

P/E13.1price / net income over 12 months
P/B1.0market cap / equity
Dividend yield6.5%dividends over the last 12 months / price
12-month range₪2.48 – ₪3.16monthly closes

This company's valuation multiples history is being built day by day from now on.

P/E calculated on net income (trailing 12 months: last fiscal year + H1 2026 − same period a year earlier). Sector median: companies in the group tracked here. Prices: Yahoo Finance; market cap cross-checked with the Tel Aviv Stock Exchange for Israeli stocks. These ratios describe a price, not a value: none of them says whether the share is expensive or cheap.

Dividends

Dividend per share, over 5 years

2021202220232024₪0.122025₪0.182026 (to date)

Total dividends per share paid each calendar year (1 year(s) out of 5 with a payment). Source: Yahoo Finance. The current year is not complete.

Insiders

Trades by executives and interested parties

2 filing(s) over 12 months · on shares: 0 increase(s) and 0 decrease(s) in holdings.

DateHolderSecurityDirectionQuantityPrice
27/04/2026Shlomo Mula
Executive
OptionsDown16,000—Maya ›
31/12/2025Zichlinskey Nir
Director
OptionsDown62,580—Maya ›

Filings submitted on Maya (executives, directors, shareholders above 5%). An increase or decrease in holdings may come from a purchase or sale on the exchange, but also from a grant or exercise of options (price "—": grant with no price). Bonds excluded. For details, see the filing on Maya.

Follow earnings · WhatsApp group TA-125Details ▾
WhatsApp group · TA-125

Every report from a TA-125 company, analyzed the same day: key figures and year-on-year change, analysis in brief, share price reaction. One daily summary during earnings season.

Detailed figures and history
The figures

Financial summary

S1 2026S1 2025FY 2025
Total assets138144139
Current assets989398
Non-current assets405241
Equity103103100
of which minority interests101110
Current liabilities252828
Non-current liabilities91311
Revenue7578157
Gross profit292247
Operating income1064
Pre-tax income1064
Net income940
Net income (attributable to shareholders)1042
Dividends paid−6−4−4
Operating cash flow151518

In millions of shekels. The "H1" columns cover the first six months of the year.

Ratios

Calculated from these figures

S1 2026S1 2025FY 2025
Gross margin38.4%28.7%29.8%
Operating margin12.8%7.9%2.7%
Net margin12.9%5.5%1.0%
Current ratio (current assets / current liabilities)3,8 x3,3 x3,5 x
Equity / total assets74.8%71.6%71.5%

The 5-year history, charts and cross-check models are coming for companies listed only in Tel Aviv: each new filing on Maya is kept and enriches the page.

Company overview

Seach Medical Group Ltd manufactures and sells medicinal cannabis products worldwide. The company provides cannabis oil and medical cannabis inflorescence products. Seach Medical Group Ltd was incorporated in 1987 and is based in Ramat Gan, Israel.

Source: official company profile (Yahoo Finance), summary. Website: www.seach.co.il

Sources
Information, no recommendation. This site presents figures published by companies and calculations based on those figures. It is not investment advice, nor a recommendation to buy or sell, nor a valuation of the companies. Always check the original reports.